Three landmark studies analyzed immune cells from nearly 2,000 people, revealing how genetic variation influences disease risk and supporting the development of precision treatments for autoimmune diseases, neurological conditions, and cancer. …
Blocking the CD44 receptor alters tumor-promoting cells in the tumor microenvironment and could improve prospects for treatment of pancreatic cancer. …
Researchers have identified vulnerabilities and promising drug combinations, including repurposed medicines, that could lead to more effective personalized treatments for the most common and difficult-to-treat form of colorectal cancer. …
Long-read DNA sequencing studies found genetic alterations missed by conventional sequencing and traced the origin of a rare pediatric tumor. …
A synthetic compound uses excess carbon monoxide in tumor cells to produce anti-cancer drugs inside them, potentially destroying tumors while minimizing harm to healthy tissue. …
A new circadian subtype of depression linked to the biological clock may respond better to melatonin and light therapy than to standard antidepressants. …
Researchers identified the early changes linked to ANCA-associated glomerulonephritis, a kidney condition caused by an autoimmune disease, and investigated a treatment to halt its progression. …
Scientists have discovered that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism. …
A new study found that when plastics fragment into microplastics, their greatly increased surface area can generate reactive oxygen species that may harm biological systems, challenging the view that microplastics are chemically inert. …
An aging-specific screening platform identified a gene with multifaceted rejuvenating effects that extended healthspan and lifespan in mice. …
End of content
End of content
